Sotrovimab
So Sotrovimab which is the drug that the NHS is throwing at vulnerable COVID patients is a monoclonal antibody. AFAIK that's what Ocrevus/Ocrelizumab is (that I'm on), does that kill off it's usefulness? Could it cause problems?
We are a charity and rely on donations
Charity Number: 1117194 (England and Wales)
Registered Company: 06000961
Registered address:
Shift.ms, Platform, New Station Street, LS1 4JB, United Kingdom
London office:
Shift.ms, Somerset House, Strand, West Goods Entrance, London WC2R 1LA, United Kingdom
©2025 Shift.ms
Comment deleted.
Ok I just read a little into this treatment, so it looks like it's similar in action to Ocrevus in that it is give a target to interrupt. Ocrevus takes any B Cells with any CD20 receptors. And this Sotrovimab looks to.target specific COVID Cells to stop them working correctly. So no it shouldn't change how effective it is, as it's carpet bombing cells that shouldn't be in your body.